Parenteral Drugs (India) (BOM:524689) Total Inventories : ₹10.27 Mil (As of Mar. 2022)

Parenteral Drugs (India) Total Inventories Chart

Parenteral Drugs (India) Annual Data
	Trend	Mar13	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
Total Inventories		Get a 7-Day Free Trial					270.14	39.71	12.55	15.91	10.27

Parenteral Drugs (India) Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Total Inventories	Get a 7-Day Free Trial															15.91	-	6.40	-	10.27

Parenteral Drugs (India) Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Parenteral Drugs (India)  (BOM:524689) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Parenteral Drugs (India)'s Net-Net Working Capital Per Share for the quarter that ended in Mar. 2022 is

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Parenteral Drugs (India)'s Days Inventory for the three months ended in Mar. 2022 is calculated as:

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Parenteral Drugs (India)'s Inventory Turnover for the quarter that ended in Mar. 2022 is calculated as

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Parenteral Drugs (India)'s Inventory to Revenue for the quarter that ended in Mar. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Parenteral Drugs (India) Total Inventories Related Terms

Thank you for viewing the detailed overview of Parenteral Drugs (India)'s Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Parenteral Drugs (India) (BOM:524689) Business Description